Federal Register of Legislation - Australian Government

Primary content

PB 52 of 2011 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide for changes to the conditions subject to which payments will be made by the Commonwealth in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners.
Administered by: Health
Registered 27 Jul 2011
Tabling HistoryDate
Tabled HR18-Aug-2011
Tabled Senate18-Aug-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 52 of 2011

Amendment determination under paragraph 98C(1)(b) of the National Health Act 19531

 

I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated                           21 July                        2011

 

 

 

 

 

 

FELICITY McNEILL

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 August 2011.

2              Amendment of the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).



Schedule 1            Amendments

 

[1]        Schedule 3, entry for Fentanyl

substitute:

Fentanyl

Lozenges 200 micrograms (as citrate), 3

 

Lozenges 200 micrograms (as citrate), 30

 

Lozenges 400 micrograms (as citrate), 3

 

Lozenges 400 micrograms (as citrate), 30

 

Lozenges 600 micrograms (as citrate), 3

 

Lozenges 600 micrograms (as citrate), 30

 

Lozenges 800 micrograms (as citrate), 3

 

Lozenges 800 micrograms (as citrate), 30

 

Lozenges 1200 micrograms (as citrate), 3

 

Lozenges 1200 micrograms (as citrate), 30

 

Lozenges 1600 micrograms (as citrate), 3

 

Lozenges 1600 micrograms (as citrate), 30

 

Transdermal patch 2.1 mg

 

Transdermal patch 2.55 mg

 

Transdermal patch 4.2 mg

 

Transdermal patch 5.10 mg

 

Transdermal patch 7.65 mg

 

Transdermal patch 8.4 mg

 

Transdermal patch 10.20 mg

 

Transdermal patch 12.6 mg

 

Transdermal patch 16.8 mg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.frli.gov.au.